The initial public offering market is remaining red hot heading into the middle of February, with 10 traditional IPOs and 3 special purpose acquisition companies (SPAC) looking to raise a total of nearly $3.3 billion in debut.
In the week's largest offering, Bumble Inc. (BMBL ) plans to raise $1.19 billion from 34.5 million shares priced between $28 to $30 each. The company operates a collection of social dating and connection apps under the Bumble and Badoo names. While Bumble operates in a highly competitive market, with rivals like Match Group (MTCH ), the company offers a diverse group of social platforms and is set to benefit from the end of the coronavirus pandemic.
Here's the rest of the week's offerings in order of offering amount:
Signify Health, Inc. (SGFY ) plans to offer 23.5 million shares in the range of $17 to $19 to raise over $513 million. The company offers a value-based billing platforms for in-home and bundled health services.
loanDepot, Inc. (LDI ) plans to raise $362 million from 15 million shares offered between $19 to $21 each. The company is a nonbank lender that provides loan origination and servicing with focus on mortgages and unsecured personal loans. The company had previously postponed its IPO last week.
Viant Technology Inc. (DSP ) plans to offer 7.5 million shares in the range of $19 to $21 per share to raise over $181 million. The company offers advertising software that enables programmatic advertising.
Apria, Inc. (APR ) plans to raise over $181 million by offering 7.5 million shares between $19 to $21 each. The company provides integrated home healthcare equipment and related services in the United States, serving nearly 2 million patients and making almost 2.4 million deliveries.
Adagene Inc. (ADAG ) plans to raise $160 million from nearly 7.4 million shares between $17 to $19 each. The Chinese cancer-focused biotech lead candidate is currently in Phase I clinical trials in the United States and China.
Bioventus Inc. (BVS ) plans to raise $152 million from 7.35 million shares priced between $16 to $18 each. The company is focused on developing and commercializing clinically differentiated, cost efficient, and minimally invasive treatments to aid the body's natural healing processes.
Baosheng Media Group Holdings Ltd (BAOS ) plans to offer 5 million shares between $5 to $6 each to raise an offering of $34.5 million. The Chinese marketing services firm offers online marketing strategies, advertising optimization services, and facilitate the deployment of online advertisements.
Longeveron LLC (LGVN ) plans to raise over $31 million from nearly 2.3 million shares priced between $10 to $12 each. The cell therapy focused biotech is currently sponsoring Phase I and II clinical trials for its lead investigational development.
Vallon Pharmaceuticals, Inc. (VLON ) plans to raise over $19 million from 1.67 million shares priced between $8 to $10 each. The biopharmaceutical company is developing prescription drugs for central nervous system disorders.
